473 studies found for:    HIV OR AIDS | Open Studies | NIH
Show Display Options
Rank Status Study
21 Unknown  Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and Thailand
Condition: HIV Infections
Interventions: Behavioral: Community-Based HIV VCT;   Behavioral: Standard clinic-based VCT
22 Recruiting Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Placebo
23 Recruiting Lymphocyte Infusions for the Treatment of HIV-Infected Patients Failing Anti-HIV Therapy
Condition: HIV Infections
Intervention: Drug: Cell Transfer
24 Not yet recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma
Conditions: HIV Infection;   HIV-associated Hodgkin Lymphoma;   Stage II Adult Hodgkin Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage IV Adult Hodgkin Lymphoma
Interventions: Drug: brentuximab vedotin;   Drug: doxorubicin hydrochloride;   Drug: vinblastine;   Drug: dacarbazine;   Other: pharmacological study;   Other: laboratory biomarker analysis
25 Unknown  Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From Prison
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Intervention: Behavioral: Structured Ecosystems Therapy (SET)
26 Recruiting Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
Conditions: Hepatitis;   HIV/AIDS
Interventions: Drug: Boceprevir;   Drug: Peg-Interferon-alfa 2B;   Drug: Ribavirin
27 Unknown  A School-Based HIV/STD Prevention Program to Reduce Risky Sexual Behaviors Among Adolescents in Liberia
Condition: HIV Infections
Interventions: Behavioral: HIV/STD prevention curriculum;   Behavioral: General health promotion curriculum;   Behavioral: Pilot-testing activities
28 Recruiting Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention
Condition: HIV Infection
Intervention: Behavioral: Community Mobilization
29 Recruiting Acute HIV Infection Observational Study
Condition: HIV Infections
Intervention:
30 Not yet recruiting Safety and Pharmacokinetics of Raltegravir in HIV-1-Exposed Newborn Infants at High Risk of Acquiring HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir
31 Unknown  Effects of HIV and Hepatitis C Virus on the Brain
Conditions: HIV Infections;   Hepatitis C
Intervention:
32 Recruiting Antiretroviral Drug Interaction Study in Volunteers With HIV
Conditions: HIV;   PCP;   Toxoplasmosis
Interventions: Drug: Atovaquone 750 mg twice daily;   Drug: Atovaquone 1500 mg twice daily
33 Unknown  HIV Antiretroviral Drugs and Metabolism
Condition: HIV Infections
Intervention: Drug: ritonavir, lopinavir/ritonavir, atazanavir/ritonavir, efavirenz
34 Not yet recruiting Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Lopinavir/ritonavir;   Drug: Efavirenz;   Drug: Raltegravir
35 Unknown  Resistance to HIV Infection
Condition: HIV Infections
Intervention:
36 Recruiting Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
Condition: HIV Infection
Intervention: Drug: Interferon Alpha 2b
37 Recruiting A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries
Condition: HIV
Intervention:
38 Recruiting Clinical and Immunologic Monitoring of Patients With Known or Suspected HIV Infection
Conditions: HIV Infections;   AIDS;   Opportunistic Infections
Intervention:
39 Recruiting Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
Condition: HIV Infections
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
40 Recruiting Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in Men Who Have Sex With Men and in At-Risk Women
Condition: HIV Infection
Interventions: Drug: Maraviroc;   Drug: Emtricitabine;   Drug: Tenofovir disoproxil fumarate;   Other: Maraviroc placebo;   Other: Emtricitabine placebo;   Other: Tenofovir disoproxil fumarate placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years